Recognising these early warning signs is key, especially if youre taking GLP-1 medications and your eating habits have changed
The first athlete progresses normally
Crucially, these pharmacologically induced changes compound an underlying vulnerability: individuals with psychiatric disorders show a higher baseline prevalence of insulin resistance, metabolic syndrome, and type 2 diabetes, even in young, non-obese populations [45,57]
During the week of June 15, 2026, FDA issued 25 warning letters to telehealth companies over alleged false or misleading promotional claims about compounded GLP-1 productsclaims the agency views as violating the Federal Food, Drug, and Cosmetic Acts (FDCA) misbranding provisions, including Sections 502(a) and 502(n)
Take the first step toward a healthier, happier you